机构

• 上海药物研究所 [26]
• 上海生物化学与细胞生... [4]
• 长春应用化学研究所 [3]
• 合肥物质科学研究院 [2]
• 金属研究所 [1]
• 长春光学精密机械与物... [1]
• 更多

采集方式

• OAI收割 [46]
• iSwitch采集 [2]

内容类型

• 期刊论文 [47]
• 学位论文 [1]

发表日期

• 2023 [5]
• 2022 [3]
• 2021 [3]
• 2020 [4]
• 2019 [2]
• 2018 [9]
• 更多

学科主题

• Biochemist... [2]
• Biology; M... [1]
• Cell Biolo... [1]
• Chemistry,... [1]
• Engineerin... [1]

筛选

浏览/检索结果: 共48条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 卷号: 55, 期号: 12, 页码: 1884-1891 作者:     |  收藏  |  浏览/下载：8/0  |  提交时间：2024/02/27 dihydrocelastrol  multiple myeloma  JAK2/STAT3  PSMB5  bortezomib resistance   TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage 期刊论文  OAI收割 CANCER MEDICINE, 2023, 页码: 14 作者:  Chang, Shuaikang;  Xiao, Wenqin;  Xie, Yongsheng;  Xu, Zhijian;  Li, Bo   |  收藏  |  浏览/下载：5/0  |  提交时间：2023/12/11 DNA damage  DSBs repair  myeloma  TI17  Trip13   Proteasome inhibitors reduce CD73 expression partly via decreasing p-ERK in NSCLC cells 期刊论文  OAI收割 LIFE SCIENCES, 2023, 卷号: 332, 页码: 10 作者:  Su, Ai-Ling;  Tian, Chang-Qing;  Ou, Ying-Jie;  Bao, Xu-Bin;  Huan, Xia-Juan   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/12/08 CD73  Proteasome inhibitors  ERK  NSCLC   Exploration of novel four-membered-heterocycle constructed peptidyl proteasome inhibitors with improved metabolic stability for cancer treatment 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2023, 卷号: 138, 页码: 22 作者:  Wang, Hanlin;  Wu, Zhaoxiao;  Cao, Yu;  Gao, Lixin;  Shao, Jiaan   |  收藏  |  浏览/下载：13/0  |  提交时间：2023/10/17 Metabolic stability  Four-membered heterocycles  Proteasome inhibitors  Multiple myeloma   A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 卷号: 55, 期号: 2, 页码: 215 作者:  Zhang Bibo;  Li Bo;  Xie Yongsheng;  Chang Shuaikang;  Xu Zhijian   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/07/18 DCZ0358  apoptosis  cell cycle arrest  multiple myeloma  JAK2/STAT3 pathway   ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2022, 卷号: 13, 期号: 1, 页码: 20 作者:  Li, Ni;  Liu, Qiuli;  Han, Ying;  Pei, Siyu;  Cheng, Bisheng   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/04/10 Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma 期刊论文  OAI收割 Journal of Biomedical Science, 2022, 卷号: 29, 期号: 1 作者:  Xie,Yongsheng;  Wang,Yingcong;  Xu,Zhijian;  Lu,Yumeng;  Song,Dongliang   |  收藏  |  浏览/下载：26/0  |  提交时间：2022/06/15 4-Hydroxysalicylanilid  Ribonucleotide reductase  Deoxyribonucleotides  DNA damage repair  Multiple myeloma   Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 233, 页码: 18 作者:  Cao, Yu;  Tu, Yutong;  Fu, Liping;  Yu, Qian;  Gao, Lixin   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/06/15 Metabolism  Design  Proteasome inhibitors  Non-covalent  Multiple myeloma   The Combination of Bortezomib with Cyclophosphamide, Epirubicin, Etoposide and Prednisone (BCHEP) Regimen As First-Line Treatment for Untreated Patients with Peripheral T Cell Lymphoma: A Prospective, Single Arm, Phase II Study 期刊论文  OAI收割 BLOOD, 2021, 卷号: 138 作者:  Yang, Haiyan;  Li, Cong   |  收藏  |  浏览/下载：2/0  |  提交时间：2022/12/23 RNA-binding protein 39: a promising therapeutic target for cancer 期刊论文  OAI收割 CELL DEATH DISCOVERY, 2021, 卷号: 7, 期号: 1, 页码: 9 作者:  Xu, Caipeng;  Chen, Xiaohua;  Zhang, Xuetian;  Zhao, Dapeng;  Dou, Zhihui   |  收藏  |  浏览/下载：43/0  |  提交时间：2021/12/08